CIK 0001404644
- Non-accelerated filer
- Smaller reporting company
Neurogene Inc.
Sign in to watch- Ticker
- NGNE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 980542593
- Phone
- +1 877-237-5020
- Business address
- 535 W 24TH STREET, 5TH FLOOR, NEW YORK, NY, 10011
- Former names
- Neoleukin Therapeutics, Inc., AQUINOX PHARMACEUTICALS, INC, AQUINOX PHARMACEUTICALS (USA) INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-08-12 | MacKenzie Lloyd VP Technical Operations | Exercise or conversion | +7,812 | $5.76 | $45K | 7,812 |
| 2015-08-12 | MacKenzie Lloyd VP Technical Operations | Exercise or conversion | +28,075 | $5.76 | $162K | 35,887 |
| 2015-08-12 | MacKenzie Lloyd VP Technical Operations | Sale | −35,887 | $18.67 | $670K | 0 |
| 2015-08-12 | MacKenzie Lloyd VP Technical Operations | Exercise or conversion · Stock Option (Right to Buy) | +7,812 | 0 | ||
| 2015-08-12 | MacKenzie Lloyd VP Technical Operations | Exercise or conversion · Stock Option (Right to Buy) | +28,075 | 1,872 | ||
| 2015-08-12 | Alam Kamran CFO, Vice President Finance | Exercise or conversion | +8,246 | $5.76 | $47K | 8,246 |
| 2015-08-12 | Alam Kamran CFO, Vice President Finance | Exercise or conversion | +20,833 | $5.76 | $120K | 29,079 |
| 2015-08-12 | Alam Kamran CFO, Vice President Finance | Sale | −29,079 | $18.67 | $543K | 0 |
| 2015-08-12 | Alam Kamran CFO, Vice President Finance | Exercise or conversion · Stock Option (Right to Buy) | −8,246 | 2,170 | ||
| 2015-08-12 | Alam Kamran CFO, Vice President Finance | Exercise or conversion · Stock Option (Right to Buy) | −20,833 | 0 | ||
| 2015-08-11 | Mitchell David Chilton VP Global Regulatory & Quality | Purchase | +1,600 | $24.36 | $39K | 1,600 |
| 2015-08-11 | JOHNSON & JOHNSON 10% owner | Sale | −1,283,366 | $20.74 | $26.6M | 100,000 |
| 2015-08-10 | PFIZER INC 10% owner | Sale | −18 | $29.00 | $522 | 1,235,312 |
| 2015-08-10 | PFIZER INC 10% owner | Sale | −2,840 | $41.25 | $117K | 1,232,472 |
| 2015-08-10 | PFIZER INC 10% owner | Sale | −2,975 | $28.47 | $85K | 1,229,497 |
| 2015-08-10 | PFIZER INC 10% owner | Sale | −3,207 | $35.61 | $114K | 1,226,290 |
| 2015-08-10 | PFIZER INC 10% owner | Sale | −6,073 | $40.30 | $245K | 1,220,217 |
| 2015-08-10 | PFIZER INC 10% owner | Sale | −8,565 | $27.36 | $234K | 1,211,652 |
| 2015-08-10 | PFIZER INC 10% owner | Sale | −8,969 | $21.45 | $192K | 1,202,683 |
| 2015-08-10 | PFIZER INC 10% owner | Sale | −9,142 | $39.52 | $361K | 1,193,541 |
Page 21 of 27 · 537 trades